Skip to main content

Advertisement

SpringerLink
Log in

Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The aim of the present study was to investigate ECLomas and enterochromaffin-like (ECL) cell hyperplasia in gastric human mucosa regarding the immunohistochemical expression of chromogranin A (CgA) epitopes and to measure the same CgA epitopes in plasma samples. Eight gastric biopsies from ECLomas, seven of type I and one of type III, and biopsies from one patient showing only ECL cell hyperplasia were included in the study. Our results revealed a varying expression of region-specific CgA epitopes in the ECLomas regarding both the frequency of immunoreactive cells and intensity of immunoreactivity. CgA284–301 (pancreastatin) was not revealed in any neoplasm, whereas CgA361–372 (catestatin) was expressed in all ECLomas. However, the number of immunoreactive cells to vesicular monoamino transporter 2 (VMAT 2) or the commercial monoclonal CgA (CgA250–284) antibodies were generally higher. The plasma concentrations of the region-specific CgA radioimmunoassays differed considerably, with highest concentrations of CgA1–17 and CgA116–130 epitopes and the lowest with the CgA17–37, CgA63–76, CgA238–247 and CgA441–424 epitopes. No relationship was found between tissue expression and plasma concentration of CgA epitopes. In conclusion, this study shows that VMAT 2 and the commercial CgA antibodies seem more useful for histopathological diagnosis of ECLomas than the antibodies to the other CgA regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cadiot G, Lehy T, Mignon M (1993) Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger–Ellison syndrome. Acta Oncol 32:135–140

    Article  PubMed  CAS  Google Scholar 

  2. Conlon JM, Hamberger B, Grimelius L (1992) Isolations of peptides arising from the specific post-translational processing of chromogranin A and chromogranin B from human pheochomocytoma tissue. Peptides 13:639–644

    Article  PubMed  CAS  Google Scholar 

  3. Creutzfeldt W (1988) The achlorydria-carcinoid sequence: role of gastrin. Digestion 39:61–79

    PubMed  CAS  Google Scholar 

  4. Cui G, Qvigstad G, Falkmer S, Sandvik AK, Kawase S, Waldum HL (2000) Spontaneous ECLomas in cotton rats (Sigmodon hispidus): tumors occurring in hypoacidic/hypergastrinaemic animals with normal parietal cells. Carcinogenesis 21:23–27

    Article  PubMed  CAS  Google Scholar 

  5. Curry WJ, Shaw C, Johnston CF, Thim L, Buchanan KD (1992) Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett 301:319–321

    Article  PubMed  CAS  Google Scholar 

  6. Drees BM, Rouse J, Johnson J, Hamilton JW (1991) Bovine parathyoid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology 129:3381–3387

    Article  PubMed  CAS  Google Scholar 

  7. Eissele R, Anlauf M, Schafer MK, Eiden LE, Arnold R, Weihe E (1999) Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. Digestion 60:428–439

    Article  PubMed  CAS  Google Scholar 

  8. Eskeland NL, Zhou A, Dinh TQ, Wu H, Parmer RJ, Mains RE, O’Connor DT (1996) Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J Clin Invest 98:148–156

    PubMed  CAS  Google Scholar 

  9. Fasciotto BH, Trauss CA, Greely GH, Cohn DV (1993) Parastatin (porcine chromogranin A 347–419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology 133:461–466

    Article  PubMed  CAS  Google Scholar 

  10. Galindo E, Rill A, Bader MF, Aunis D (1991) Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin secretion. Proc Natl Acad Sci U S A 88:1426–1430

    Article  PubMed  CAS  Google Scholar 

  11. Granberg D, Wilander E, Stridsberg M, Granerus G, Skogseid B, Öberg K (1998) Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 43:223–228

    Article  PubMed  CAS  Google Scholar 

  12. Hakanson R, Ding KQ, Norlen P, Chen D (1995) Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 108:1445–1452

    Article  PubMed  CAS  Google Scholar 

  13. Helle KB, Aardal S, Reed RK, Elsayed S (1990) N-terminal fragment of bovine chromogranin A inhibits the contractile response to endothelin-1 in human venous and arterial isolated fragments. J Physiol (London) 430:40P

    Google Scholar 

  14. Hsu SM, Raine T, Fanger H (1981) Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    PubMed  CAS  Google Scholar 

  15. Kirchmair R, Leitner B, Fischer-Colbrie R, Marksteiner J, Hogue-Angeletti R, Winkler H (1995) Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues. Biochem J 310:331–336

    PubMed  CAS  Google Scholar 

  16. Kleveland PM, Haugen SE, Waldum HL (1985) The preparation of bioactive 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies. Scand J Gastroenterol 20:569–576

    Article  PubMed  CAS  Google Scholar 

  17. Krüger PG, Mahata SK, Helle KB (2003) Catestatin (CgA344–364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides. Regul Pept 114:29–35

    Article  PubMed  CAS  Google Scholar 

  18. Lloyd RV, Wilson BS (1983) Specific endocrine tissue marker defined by a monoclonal antibody. Science 222:628–630

    Article  PubMed  CAS  Google Scholar 

  19. Mahata SK, O’Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autocrine feed-back control of catecholamin release. A discrete chromogranin A fragment is a noncompetitive nicotin cholinergic antagonist. J Clin Invest 100:1623–1633

    PubMed  CAS  Google Scholar 

  20. Muller J, Kirchner T, Muller-Hermelink HK (1987) Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol 11:909–917

    Article  PubMed  CAS  Google Scholar 

  21. O’Connor DT, Takiyyuddin MA, Cervenka JH, Parmer RJ, Barbosa JA, Chang YM, Hsiao RJ (1990) Circulating chromogranin A as a diagnostic tool in clinical chemistry. Acta Histochem Suppl 38:27–33

    PubMed  CAS  Google Scholar 

  22. Portela-Gomes GM, Stridsberg M (2001) Selective processing of chromogranin A in the different islet cells in human pancreas. J Histochem Cytochem 49:483–490

    PubMed  CAS  Google Scholar 

  23. Portela-Gomes GM, Stridsberg M (2002) Chromogranin A in the human gastrointestinal tract: an immunocytochemical study with region specific antibodies. J Histochem Cytochem 50:1487–1492

    PubMed  CAS  Google Scholar 

  24. Portela-Gomes GM, Grimelius L, Johansson H, Wilander E, Stridsberg M (2001) Chromogranin A in human neuroendocrine tumors—an immunohistochemical study with region-specific antibodies. Am J Surg Pathol 25:1261–1267

    Article  PubMed  Google Scholar 

  25. Portela-Gomes GM, Grimelius L, Stridsberg M, Puppa G, Bresaola E, Viale G, Pelosi G (2005) Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung. Virchows Arch 446:604–612

    Article  PubMed  CAS  Google Scholar 

  26. Qvigstad G, Falkmer S, Westre B, Waldum HL (1999) Clinical and histopathological tumour progression in ECL cell carcinoids (“ECLomas”). APMIS 107:1085–1092

    Article  PubMed  CAS  Google Scholar 

  27. Rappel S, Altendorf-Hofmann A, Stolte M (1995) Prognosis of gastric carcinoid tumours. Digestion 56:455–462

    PubMed  CAS  Google Scholar 

  28. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E (1996) Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 20:168–171

    Article  PubMed  CAS  Google Scholar 

  29. Roberts LJ 2nd, Bloomgarden ZT, Marney SR Jr, Rabin D, Oates JA (1983) Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin. Gastroenterology 84:272–275

    PubMed  CAS  Google Scholar 

  30. Robinson M (1999) Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia. Aliment Pharmacol Ther13:5–10

    Article  PubMed  Google Scholar 

  31. Simonsson M, Eriksson S, Hakanson R, Lind T, Lonroth H, Lundell L, O’Connor DT, Sundler F (1988) Endocrine cells in the human oxyntic mucosa—a histochemical study. Scand J Gastroenterol 23:1089–1099

    Article  PubMed  CAS  Google Scholar 

  32. Solcia E, Capella C, Sessa F, Rindi G, Cornaggia M, Riva C, Villani L (1986) Gastric carcinoids and related endocrine growths. Digestion 35:3–22

    Article  PubMed  Google Scholar 

  33. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, Grimelius L, Havu N (1988) Histopathological classification of nonantral gastric endocrine growths in man. Digestion 41:185–200

    PubMed  CAS  Google Scholar 

  34. Stridsberg M, Eriksson B, Öberg K, Janson ET (2004) A panel of 11 region-specific radioimmunoassays for measurement of human chromogranin A. Regul Pept 117:219–227

    Article  PubMed  CAS  Google Scholar 

  35. Strub JM, Sorokine O, Van Dorsselaer A, Aunis D, Metz-Boutigue MH (1997) Phosphorylation and O-glycosylation sites of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities. J Biol Chem 272:11928–11936

    Article  PubMed  CAS  Google Scholar 

  36. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD (1986) Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (London) 324:476–478

    Article  CAS  Google Scholar 

  37. Thomas RM, Baybick JH, Elsayed AM, Sobin LH (1994) Gastric carcinoids—an immunohistochemical and clinicopathologic study of 104 patients. Cancer 73:2053–2058

    Article  PubMed  CAS  Google Scholar 

  38. Waldum HL, Brenna E, Sandvik AK (1998) Relationship of ECL cells and gastric neoplasia. Yale J Biol Med 71:325–335

    PubMed  CAS  Google Scholar 

  39. Waldum HL, Sandvik AK, Idle JR (1998) Gastrin is the most important factor in ECL tumorigenesis. Gastroenterology 114:1113–1115

    Article  PubMed  CAS  Google Scholar 

  40. Wilander E, Nordgren H, Öberg K (1986) Nonantral gastric carcinoid tumours associated to hypergastrinaemia. Acta Med Scand 219:393–397

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Gastroenterology, Bellaria Hospital, University of Bologna, Via Altura 3, 40139, Bologna, Italy

    Andreas Tartaglia & Paolo Vezzadini

  2. Centre of Nutrition, University of Lisbon, Lisbon, Portugal

    Guida M. Portela-Gomes

  3. Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, Sweden

    Kjell Öberg & Mats Stridsberg

  4. Section of Anatomic Pathology at Bellaria Hospital, University of Bologna, Bologna, Italy

    Maria P. Foschini

  5. Department of Genetics and Pathology, University of Uppsala, Uppsala, Sweden

    Guida M. Portela-Gomes

Authors
  1. Andreas Tartaglia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guida M. Portela-Gomes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kjell Öberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo Vezzadini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria P. Foschini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mats Stridsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Tartaglia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tartaglia, A., Portela-Gomes, G.M., Öberg, K. et al. Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies. Virchows Arch 448, 399–406 (2006). https://doi.org/10.1007/s00428-005-0113-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-005-0113-1

Keywords

Search

Navigation